Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Azmi Nabulsi"'
Publikováno v:
Nature Reviews Drug Discovery. 18:319-320
Clinical trials for Alzheimer disease drugs have an exceptionally high failure rate, discouraging investment in the field despite the unmet medical need. Drug developers need to more effectively harness existing and emerging data and digital technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2b048bca10b1501a9aa322d6ccbd24
https://doi.org/10.1038/nrd.2018.86
https://doi.org/10.1038/nrd.2018.86
A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease
Publikováno v:
AIDS. 12:1495-1502
Background: The aim of treatment for HIV disease is prolonging survival and improvement in health-related quality of life. Ritonavir is a potent, orally bioavailable HIV protease inhibitor with demonstrated impact on surrogate endpoints, AIDS-definin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fff3493db302a1639f093f33cc7e05c0
https://doi.org/10.1097/00002030-199812000-00012
https://doi.org/10.1097/00002030-199812000-00012
Autor:
Myra A. Carpenter, Aaron R. Folsom, Ralph W. Barnes, Azmi Nabulsi, Moyses Szklo, Paul D. Sorlie, Jasenka Demirovic
Publikováno v:
Circulation. 88(6)
BACKGROUND Although much has been written in recent years about the relation between alcohol and atherosclerotic disease, controversy exists as to whether and how alcohol exerts an effect on atherosclerosis in different sites. METHODS AND RESULTS We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::773f20e06515ec9de962df7163938852
https://pubmed.ncbi.nlm.nih.gov/8252692
https://pubmed.ncbi.nlm.nih.gov/8252692